Dementia is thought to occur when proteins called amyloid-β, tau, and α-synuclein accumulate in the brain and form oligomers. A research group from the Department of Translational Neuroscience, Osaka City University Graduate School of Medicine, had previously shown in a study using mice that the antibiotic rifampicin removes oligomers from the brain and improves cognitive function. However, the drug has been associated with side effects such as liver damage.
Stopping dementia at the nose with combination of rifampicin and resveratrol
December 28, 2021
Related blog posts
New drug shows promise for fighting both COVID-19 and cancer
November 15, 2022